News

Insightful Earnings Preview for Agilysys Set to Impress Investors

Insightful Earnings Preview for Agilysys Set to Impress Investors

Upcoming Earnings Report for Agilysys

Agilysys (NASDAQ: AGYS) is gearing up to release its quarterly earnings report soon, and anticipation is building among investors. The forthcoming announcement promises valuable information for those interested in the company and its future performance.

Analysts' Earnings Expectations

Experts forecast that Agilysys will report an earnings per share (EPS) of $0.32. This figure holds significance as market watchers closely evaluate how the company performs against these estimates.

Investors are eagerly awaiting updates on whether the company can exceed these expectations and provide a positive outlook for the upcoming quarter. Predictions and guidance can heavily influence stock price movements, making it crucial for stakeholders to stay informed.

Historical Earnings Trends

Reflecting on past performance, Agilysys previously surpassed its EPS estimate by $0.25, leading to a remarkable 22.1% rise in share price the following day. This historical data contributes to a positive sentiment heading into the next earnings announcement.

Here is a snapshot of Agilysys's previous earnings results and corresponding share price changes:

Quarterly Earnings and Market Reaction

Quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025
EPS Estimate 0.29 0.34 0.30 0.25
EPS Actual 0.54 0.38 0.34 0.30
Price Change % 22.0% -20.0% -8.0% -5.0%

Current Stock Performance

As of mid-July, Agilysys shares were trading at $119.39, reflecting a 4.94% rise over the past year. Long-term shareholders are likely to feel optimistic about the upcoming earnings report, bolstered by these generally positive returns.

Understanding Analysts' Insights

It’s essential for investors to gauge market sentiment regarding Agilysys. The company has received two ratings from analysts, with a consensus rating of "Buy." The average one-year price target for the stock is $115.0, indicating a potential downside of approximately 3.68% based on current trading levels.

Comparative Analysis with Peers

To enhance investment decisions, it’s important to analyze Agilysys's performance relative to its industry peers such as Asana, Intapp, and BlackLine. The following comparisons highlight analyst ratings and market positions:

  • Asana is viewed neutrally, with an average one-year price target of $16.38, pointing to a significant downside potential of 86.28%.
  • Intapp, meanwhile, has a "Buy" recommendation with a projected price target of $61.43, indicating a downside of 48.55%.
  • BlackLine also retains a neutral designation, at an average price target of $53.20, suggesting potential downside of 55.44%.

Key Insights from Peer Evaluations

The summary of peer evaluations shows that Agilysys excels in revenue growth with a rate of 19.37%. However, it ranks lower in gross profit and return on equity metrics:

Company Consensus Revenue Growth Gross Profit Return on Equity
Agilysys Buy 19.37% $45.05M 1.50%
Asana Neutral 8.59% $168.04M -17.26%
Intapp Buy 16.66% $96.41M -0.61%
BlackLine Neutral 6.01% $126.01M 1.40%

Company Overview

Agilysys Inc specializes in hospitality software, offering cloud-native SaaS and on-premise solutions tailored to various sectors, including hotels, resorts, cruise lines, and healthcare facilities. Their product offerings encompass point-of-sale systems, property management solutions, and comprehensive applications designed to enhance the guest experience.

Financial Performance Highlights

Market Capitalization: The company showcases a robust market capitalization, indicating a strong market presence.

Revenue Growth: Over a period of three months ending March 31, 2025, Agilysys achieved a revenue growth rate of approximately 19.37%, reflecting significant improvements in their top-line earnings.

Profitability Metrics: Despite strong revenue growth, Agilysys's net margin of 5.28% suggests challenges in achieving high profitability. However, its return on equity of 1.5% indicates strong financial management.

Debt Position: The company's debt-to-equity ratio is a prudent 0.18, highlighting balanced debt management strategies.

Frequently Asked Questions

What is the anticipated EPS for Agilysys?

The expected earnings per share (EPS) for Agilysys is $0.32.

When will Agilysys release its earnings report?

Agilysys is set to release its quarterly earnings report soon, with the specific date being eagerly awaited.

How did Agilysys perform in previous earnings?

In the last quarter, Agilysys beat EPS estimates by $0.25, resulting in a 22.1% increase in share price the following day.

What stock price movement is expected around the earnings release?

Given positive historical trends, there is anticipation of potential stock price movements based on performance relative to expectations and guidance.

What is Agilysys's market focus?

Agilysys provides hospitality software solutions, serving markets including hotels, casinos, and healthcare facilities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Haier and UEFA's Deal: A Game-Changer for Fans?

Updated Category News Views 1

A Bold Play in the Global Arena There's something big brewing on the horizon, as Haier aligns with the UEFA Champions League. From 2027 to 2031, this move isn't just about slapping a logo on a jersey. Nah, it's more than that. Haier's stepping up its game, aiming to become a real player in weaving technology and sports into the daily lives of millions. "We aim to bring...

Continue Reading
Cango's EcoHash Marks AI Move with Key Milestones

Updated Category News Views 4

AI Expansion at EcoHash: A Strategic Stride Some days you wake up, read a company pushing its legacy into something new, and you just gotta wonder if they’ve hit paydirt or just blowing smoke. For Cango Inc. and its subsidiary EcoHash, this latest update is shaping up interesting. They're no small potatoes in mining Bitcoins, but they're now trying their hand at AI...

Continue Reading
Windows Storage Trends Shift: SSD Dominates 2026

Updated Category News Views 0

SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...

Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

Updated Category News Views 2

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Continue Reading
PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Updated Category News Views 2

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Continue Reading
PlugClaw: TrustKernel's AI Gadget Tackles Privacy Hurdles

Updated Category News Views 0

A Handy Revolution in AI Computing You know, every now and then, a gadget shows up that flips the scene on its head. Enter TrustKernel's PlugClaw. It's not every day you see a whole computer in something barely the size of your thumb, yet this one does exactly that. Weighing in at a measly 15 grams and armed with a MediaTek Helio G80, we're looking at a USB-C stick that's...

Continue Reading
PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 2

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 2

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
Lyntris Advances KSAT Hyperion Satellite Program Milestone

Updated Category News Views 1

Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...

Continue Reading

Top 5 Most Recently Viewed Articles

Sling Therapeutics Welcomes Andrew Guggenhime to Board

Updated Category News Views 163

Sling Therapeutics Welcomes Andrew Guggenhime to Board Sling Therapeutics, Inc., a biopharmaceutical company known for its advancements in the treatment of thyroid eye disease (TED), has recently announced a significant addition to its team. Andrew Guggenhime, an accomplished executive in the biotechnology field, is joining the company's Board of Directors. Bringing...

Continue Reading
Shoptalk Luxe to Transform Luxury Retail in Abu Dhabi

Updated Category News Views 128

Shoptalk Luxe Set to Redefine Luxury Retail Abu Dhabi is gearing up to host the first Middle East edition of Shoptalk Luxe, scheduled for late January 2026. This exciting event is anticipated to attract over 2,000 participants and more than 170 distinguished speakers from around the globe, all converging in the UAE capital to explore the innovative trends redefining...

Continue Reading
Discovering the Growth Potential of Capital One Stock

Updated Category News Views 278

Analyzing Capital One Financial Corp's Stock Performance Capital One Finl (NYSE: COF) has certainly made waves in the financial market. Over the past five years, this robust financial institution has outperformed expectations, boasting an impressive 5.94% annualized growth rate. Investors have seen an average annual return of 19.2%, which is commendable considering the...

Continue Reading
Evolectric and Geotab Forge Partnership to Drive EV Fleet Solutions

Updated Category News Views 99

Evolectric and Geotab Team Up for Electric Fleet Transformation Evolectric, recognized for its cutting-edge circular electric vehicle technology, has just revealed a strategic partnership with Geotab, a frontrunner in connected transportation solutions. This collaboration aims to transform how fleet owners tackle electrification by merging Evolectric's unique software...

Continue Reading
Export Development Canada Celebrates Major Loan to Lotte Shopping

Updated Category News Views 176

Major Financing Initiative by EDC for Lotte Shopping This significant step marks Export Development Canada’s (EDC) inaugural financing in South Korea through a $200 million loan to Lotte Shopping Co., Ltd., enhancing retail operations and laying the groundwork for future collaborations. Details of the Financing Deal Of the total loan, $150 million is guaranteed by EDC...

Continue Reading